The offer is made via TW Troy, a vehicle held by Tamarind Health, whose investors include Hong Kong-based Templewater and 65 Equity Partners.
Medical group Tamarind Health, with the backing of investors including Temasek unit 65 Equity Partners, is offering 45.6 cents per share to privatise cancer specialist TalkMed Group, valuing the company at more than $606 million.
As part of its longer-term growth plans, the enlarged entity might then seek its own listing on the Singapore Exchange (SGX:S68
) .
